NCT07017790View on ClinicalTrials.gov

Amino Acid PET to Assess the Efficacy of IDH Inhibitor Treatments for IDH Mutated Gliomas

Not yet recruitingOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

July 1, 2025

Study Completion Date

August 30, 2025

Conditions
Glioma
Interventions
OTHER

Amino-acid PET

Patients received 18-fluoroDopa then a PET exam

Trial Locations (1)

54511

CHRU of NANCY, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT07017790 - Amino Acid PET to Assess the Efficacy of IDH Inhibitor Treatments for IDH Mutated Gliomas | Biotech Hunter | Biotech Hunter